Prevail Therapeutics
Paul Tamburri has extensive experience in clinical development and translational medicine, currently serving as Director of Clinical Development at Prevail Therapeutics. Previously, Paul held multiple roles at Roche, including Senior Scientist in Translational Medicine with a focus on Neuroscience, Clinical Science Specialist in Translational Medicine-Neuroscience, and Program Manager/Senior Program Manager in Regulatory Affairs for CMC Biologics. This diverse background highlights a strong expertise in bridging scientific research and clinical applications within the neuroscience field.
This person is not in any teams
Prevail Therapeutics
Prevail Therapeutics are developing novel gene therapies that target the root genetic causes of Parkinson’s disease and other neurodegenerative disorders.